How the Medical Device Industry is Being Regulated in 2023

Provided by Titanium Processing Center – a titanium company

Given their wide range, transformation by evolving technology, and associated risks, the regulation of medical devices varies from the regulation of medical products and is more complex. However, like medical products, the Food and Drug Administration is liable to regulate medical devices and to ensure their safety and effectiveness. The Center for Devices and Radiological Health in the FDA is the department that is mainly responsible for medical device regulation. 

Here are some regulatory controls that the medical device industry is subjected to. 

Medical Device Classification

Based on the level of associated risks, the medical devices are categorized into regulatory classes I, II, and III, with Class I classified as low risk and Class III devices considered to have the highest level of risk. Here is a detailed description of medical device classification. While most Class I devices are exempt from premarket approval, it is a must for devices in Class II and III.

Registration of Establishment 

Domestic and foreign manufacturers and distributors are required to register electronically with the FDA for a certain fee. The duration for verification of registration information is between 1^st October and 31^st December every year. Foreign manufacturers are also required to appoint a local agent.

Listing of Medical Devices

At the time of registration, the applicants must also file a list of devices with the FDA. The devices must be listed under their proprietary names. The listing process must be done within thirty days of initiating the manufacturing process, along with the initial registration. The listing process is also repeated at the time of annual registration. The listing information is reviewed and can be modified to accommodate any changes.

Premarket Notification and Approval

If the medical device requires a premarket notification, conventionally known as 510(K), its commercial distribution is not possible until the FDA issues approval. The 510(K) notification validates that the FDA has determined the device to be substantially equivalent to a device approved for commercial distribution in the US.

Another requirement is the premarket approval that is required mainly for Class III high-risk devices. The premarket approval process is comprehensive and requires clinical data to validate claims regarding the device’s functions and capabilities. 

To conduct a clinical study for acquiring premarket approval and notification, an investigational device exemption must be obtained to allow the use of the device in the study. An institutional review board issues approval for commencing the clinical study in concurrence with the FDA.

Quality System Regulations

The next regulatory requirement pertains to quality systems. The processes used in the design, manufacturing, packaging, labeling, and servicing of medical devices must be in accordance with the quality system regulation. The FDA may inspect the manufacturing facility to ensure the processes comply with the quality system requirements.

Medical Device Labeling and Reporting

The labels on the medical devices must be descriptive and comprise information for device features and usage. Reporting is another important aspect of medical device regulation. For this purpose, the FDA has a medical device reporting program in place that supervises reporting of any malfunctions, incidents, injuries, or even deaths caused by a certain device. The reports are then submitted to the FDA for further monitoring, analysis, assessment, and appropriate corrective actions.

Conclusion

Regulatory controls aim to ensure that medical devices are effective and safe for use and not degraded before they are approved for use. Hence they are regulated according to the extent of risk they pose to potential users. 

While general controls like device listing and registration are designed to ensure the safety of devices when they are commercially available, high-risk devices must comply with special regulatory requirements, including clinical studies and specific labeling, before they are approved for use. In case of discrepancies or regulation violations, the FDA may take corrective action against the violator, including the manufacturers, distributors, or importers.